Tawfik Wael, El-Sherif Amr, Bendary Ahmed, Mahros Mohammed, Salem Mohamed
Cardiology Department, Benha Faculty of Medicine, Benha University, Benha, Egypt.
Echocardiography. 2020 Apr;37(4):570-577. doi: 10.1111/echo.14648. Epub 2020 Apr 2.
Predicting left ventricle (LV) remodeling is important for outcome prediction in patients with ST-segment elevation myocardial infarction (STEMI). Novel echocardiographic techniques may be beneficial for those patients.
We hypothesized that the semiautomated calculation of baseline global longitudinal strain (GLS) can predict LV remodeling and 6-month clinical outcomes in these patients.
During the period from March to December 2018, 130 patients with successful reperfusion of STEMI were prospectively included. Within 48 hours, patients underwent a baseline GLS study with follow-up study at 6 months. Patients were divided into two groups: group I: patients who showed adverse LV remodeling and group II: patients who did not. The endpoint was a composite of cardiovascular mortality, readmission due to heart failure, and urgent revascularization.
The mean baseline GLS changed from -13.1 ± 3.5% for group I and -16.8 ± 3.1% for group II, to -10.2 ± 4.7% and -12.6 ± 3.1%, respectively, at 6-month follow-up. ROC analysis demonstrated a cutoff value of baseline GLS > -12.5% predicted LV remodeling with 64.5% sensitivity and 89% specificity (AUC 0.797, 95% CI 0.690-0.904). Multivariate logistic regression analysis model using 6-month MACEs occurrence as a dependent factor showed baseline GLS value> -12.5% to be the only significant independent predictor MACEs occurrence (OR 0.704, 95% CI 0.597-0.829, P < .001). Linear regression analysis showed that for every point estimate deterioration of baseline GLS, there was a significant corresponding 2.55 mL increase in LVEDV at 6-month follow-up (CI -4.501 to -0.612, P = .01).
GLS measurement can predict remodeling and adverse clinical events in STEMI patients.
预测左心室(LV)重构对于ST段抬高型心肌梗死(STEMI)患者的预后预测很重要。新型超声心动图技术可能对这些患者有益。
我们假设基线整体纵向应变(GLS)的半自动计算可以预测这些患者的LV重构和6个月临床结局。
在2018年3月至12月期间,前瞻性纳入130例STEMI成功再灌注患者。在48小时内,患者接受基线GLS研究,并在6个月时进行随访研究。患者分为两组:I组:出现不良LV重构的患者;II组:未出现不良LV重构的患者。终点是心血管死亡、因心力衰竭再次入院和紧急血运重建的复合终点。
I组平均基线GLS从-13.1±3.5%,II组从-16.8±3.1%,在6个月随访时分别变为-10.2±4.7%和-12.6±3.1%。ROC分析显示,基线GLS>-12.5%的截断值预测LV重构的敏感性为64.5%,特异性为89%(AUC 0.797,95%CI 0.690-0.904)。以6个月主要不良心血管事件(MACEs)发生情况作为因变量的多因素逻辑回归分析模型显示,基线GLS值>-12.5%是MACEs发生的唯一显著独立预测因素(OR 0.704,95%CI 0.597-0.829,P<.001)。线性回归分析显示,基线GLS每恶化一个点估计值,6个月随访时左心室舒张末期容积(LVEDV)相应显著增加2.55 mL(CI -4.501至-0.612,P = 0.01)。
GLS测量可预测STEMI患者的重构和不良临床事件。